Dive Brief: Novartis has won Food and Drug Administration approval to sell a radiopharmaceutical designed to treat a form of advanced prostate cancer in a …
ECYT lives squarely in small-cap territory. And that’1018s not a bad thing in 2018. On a year-to-date basis, the small-cap focused Russell 2000 Index has …
